OverviewSuggest Edit

Pixium Vision is developing retinal implant systems for patients who have lost their sight, with the intention of improving their vision and enabling them to lead more independent lives. The Company intends to harness the rapid advances being made in neural processing, micro-electronics and computing to develop retinal implant systems that for blind people could ultimately provide vision approaching that of a normal healthy Pixium's first device, IRIS1 (Intelligent Retinal Implantable System), uses an epi-retinal implant (on the retinal surface) and is currently in clinical trials with the goal of obtaining CE Mark. A second generation system (IRIS2) based on the same format, but offering better visual acuity and featuring several breakthrough technologies, is also under development. In addition, Pixium is developing a sub-retinal implant system (IRIS3), based on further technological breakthroughs, which has the potential to improve vision significantly compared to IRIS1 and IRIS2. Pixium was created in Paris, France in November 2011 as a spin-out of the Vision Institute and Université Pierre et Marie Curie, and based on collaborative work involving several leading academic teams across Europe. Pixium is backed by a syndicate of blue-chip European venture capital firms including Sofinnova Partners, Omnes Capital, Abingworth, Global Life Sciences Ventures, Seventure and Polytechnos.
TypePublic
Founded2011
HQParis, FR
Websitepixium-vision.com

Latest Updates

Employees (est.) (Feb 2020)30
Job Openings1
Share Price (Oct 2017)€3.1
Cybersecurity ratingAMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Pixium Vision

Guillaume Buc

Guillaume Buc

CTO
Karine Chevrie

Karine Chevrie

Regulatory Affairs and Quality Director
Ralf Hornig

Ralf Hornig

Director of Clinical Affairs
Lloyd Diamond

Lloyd Diamond

CEO
Didier Laurens

Didier Laurens

Financial Director
Show more

Pixium Vision Office Locations

Pixium Vision has an office in Paris
Paris, FR (HQ)
74 Rue du Faubourg Saint-Antoine
Show all (1)

Pixium Vision Financials and Metrics

Pixium Vision Revenue

Market capitalization (31-Oct-2017)

40.2m

Closing stock price (31-Oct-2017)

3.1
Pixium Vision's current market capitalization is €40.2 m.
Show all financial metrics

Pixium Vision Cybersecurity Score

Cybersecurity ratingPremium dataset

A

95/100

SecurityScorecard logo

Pixium Vision Online and Social Media Presence

Embed Graph

Pixium Vision News and Updates

Pixium Vision to present at the 3rd edition of Investir Day in Paris, November 2021

Pixium Vision to present at the 3rd edition of Investir Day in Paris, November 2021

Pixium Vision announces its cash position at 30 September 2021 and provides an update on its activities and financial outlook until the end of 2022

      Pixium Vision announces its cash position at 30 September 2021 and provides an update on its activities and financial outlook until the end of 2022.

Pixium Vision announces positive long-term follow-up scientific data on PRIMA implant from Prima System French feasibility study

Pixium Vision announces positive long-term follow-up scientific data on PRIMA implant fromPrima System French feasibility study

Pixium Vision announces implantation of first patient in Germany in Prima System European pivotal trial PRIMAvera

Pixium Vision announces implantation of first patient in Germany in Prima SystemEuropean pivotal trial PRIMAvera

Pixium Vision expands collaboration with Stanford University on next generation Prima System implants

Pixium Vision expands collaboration with Stanford University on next generation Prima System implants

Pixium Vision announces geographical expansion of PRIMAvera European pivotal study with opening of first UK clinical site at Moorfields Eye Hospital

Pixium Vision announces geographical expansion of PRIMAvera European pivotal study with opening of first UK clinical site at Moorfields Eye Hospital
Show more

Pixium Vision Blogs

Pixium Vision gaining confidence in execution timeline of the PRIMAvera pivotal trial following first patient implantation in the UK

Successful implantation of the first patient in the PRIMAvera study in the UK Follows successful implantations in France and Germany PRIMAvera read-out now expected around end-2023 Download PDF The post Pixium Vision gaining confidence in execution timeline of the PRIMAvera pivotal trial followin…

Pixium Vision to present at BTIG’s Ophthalmology Day

Pixium Vision announces that Lloyd Diamond, Chief Executive Officer of Pixium Vision, and Offer Nonhoff, Chief Financial Officer of Pixium Vision, will present at the Ophthalmology Day organized by BTIG, taking place virtually on Tuesday, 30 November 2021. The presentation details are as follows: Tu…

Investir Day – November 23 interview with Lloyd Diamond

Watch the interview given by Lloyd Diamond on November 23, 2021 during Investir Day, the major Parisian meeting for independent shareholders and investors held from November 15 to 23, 2021 in Paris. Program is in French. The post Investir Day – November 23 interview with Lloyd Diamond appeared first…

Vision Rehabilitation Specialist

Download PDF Apply The post Vision Rehabilitation Specialist appeared first on Pixium Vision.

Read in Le Monde, November 10, 2021

Read in Le Monde French biotech is inventing the health of tomorrow Nuggets like Hemarina, Treefog, Mnemo or Pixium are multiplying their prowess and are now raising funds... Innovations abound in France's laboratories, and they are becoming more and more incredible. For example, Pixium Vision's b…

Lead Product Engineer

Download PDF Apply The post Lead Product Engineer appeared first on Pixium Vision.
Show more

Pixium Vision Frequently Asked Questions

  • When was Pixium Vision founded?

    Pixium Vision was founded in 2011.

  • Who are Pixium Vision key executives?

    Pixium Vision's key executives are Guillaume Buc, Karine Chevrie and Ralf Hornig.

  • How many employees does Pixium Vision have?

    Pixium Vision has 30 employees.

  • Who are Pixium Vision competitors?

    Competitors of Pixium Vision include Dutch Ophthalmic Research Center (DORC), Intersect ENT and Dynatronics.

  • Where is Pixium Vision headquarters?

    Pixium Vision headquarters is located at 74 Rue du Faubourg Saint-Antoine, Paris.

  • Where are Pixium Vision offices?

    Pixium Vision has an office in Paris.

  • How many offices does Pixium Vision have?

    Pixium Vision has 1 office.